T1	Participants 50 65	ovarian cancer:
T2	Participants 441 481	Women with newly-diagnosed epithelial OC
T3	Participants 1050 1062	recruitment.
T4	Participants 1063 1121	Seventy-seven women were evaluable for the primary outcome
T5	Participants 1614 1669	in women receiving CT for newly-diagnosed epithelial OC
